South San Francisco, CA, United States of America

Mark Karbarz

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Mark Karbarz – Innovator in Cardiovascular Research

Introduction

Mark Karbarz is an accomplished inventor based in Burlingame, California, known for his significant contributions to the field of cardiovascular research. His innovative work focuses on compounds that modulate proprotein convertase subtilisin/kexin type 9 (PCSK9), a key protein involved in cholesterol metabolism and cardiovascular health.

Latest Patents

Mark Karbarz holds a patent related to "Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9)." This patent outlines novel compounds that can bind to PCSK9, thereby modulating its biological activity. The patent also details the compositions comprising these compounds, methods of preparing them, and their applications in treating conditions and diseases linked to PCSK9.

Career Highlights

Karbarz is affiliated with Srx Cardio, LLC, where he continues to advance research in cardiovascular therapies. His work has the potential to influence the treatment of various PCSK9-related conditions, promoting better health outcomes for patients at risk of cardiovascular diseases.

Collaborations

Throughout his career, Mark has collaborated with talented colleagues such as Simeon Bowers and Jiang Zhu. These partnerships play a crucial role in enhancing research quality and driving the development of innovative therapeutic strategies.

Conclusion

Mark Karbarz stands out as a prominent inventor in the field of cardiovascular innovation. With his groundbreaking patent and commitment to advancing medical science, he continues to pave the way for new treatments that could significantly impact patient care in the realm of heart health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…